WallStreetZenWallStreetZen

How to Buy Crinetics Pharmaceuticals Stock

Crinetics Pharmaceuticals Inc

Crinetics Pharmaceuticals, Inc. , a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors.

Crinetics Pharmaceuticals stock last closed at $56.69, up 1.3% from the previous day, and has increased 91.84% in one year. It has overperformed other stocks in the Biotechnology industry by 0.87 percentage points. Crinetics Pharmaceuticals stock is currently +120.16% from its 52-week low of $25.75, and -5.58% from its 52-week high of $60.04.

At the moment, there are 80.04M CRNX shares outstanding. The market value of CRNX is $4.54B. In the past 24 hours, 356,956 CRNX shares were traded.

How to Buy Crinetics Pharmaceuticals Stock

Not sure how to invest in Crinetics Pharmaceuticals stock? Here's how.
  1. Figure out where to buy Crinetics Pharmaceuticals stock: You need to pick an online brokerage, but don't worry - we've sifted through dozens of online stock brokerages and apps to help you determine where to buy Crinetics Pharmaceuticals stock.
  2. Open a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've selected.
  3. Deposit funds into your investment account: Pick your payment method and add your information.
  4. Evaluate Crinetics Pharmaceuticals stock: The Crinetics Pharmaceuticals ticker symbol is CRNX. Is Crinetics Pharmaceuticals stock a good investment? Should you buy shares of CRNX? How do CRNX's underlying business fundamentals look? Do top analysts think Crinetics Pharmaceuticals is a good buy? Why has CRNX's stock price moved recently? (Hint: Our stock market research tools can help you figure out if CRNX is a good stock to buy).
  5. Make your CRNX buy order: Decide if you will purchase CRNX shares at the current market price or use a limit order to purchase CRNX stock at a specific price.
  6. Get the latest news on your CRNX position: Create a watchlist to keep track of your investment in Crinetics Pharmaceuticals stock.

Step 1: Figure out where to buy Crinetics Pharmaceuticals stock

You will need an online brokerage account in order to access the NASDAQ market and buy CRNX shares.

A brokerage account is an investment account that allows you to buy and sell a number of financial instruments, such as stocks, bonds, mutual funds, and ETFs.

Our preferred brokerage: eToro

Based on our analysis, eToro is the best stock brokerage. Here's why:

  • You can invest in stocks with zero commissions: Invest without paying trading commissions.
  • Buy fractional shares: Even if you can't afford a full share, you can still purchase the stock.
  • Access to world financial markets: From Technology to Industrials, New York to Hong Kong — you can fill your portfolio with stocks from the globe's leading stock exchanges.
  • Social investing: eToro has a community with more than 20 million users globally. Talk to, learn from, and copy the crypto trades of other investors.
  • Security: eToro is a regulated and licensed fintech leader.
  • Buy other financial assets: Such as ETFs and cryptos.

Get $10 towards your purchase of stock by creating an account with eToro today.

Open eToro Account
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.

Step 2: Open a brokerage account

Now that you've selected your brokerage, you need to fill out some personal details so you can buy CRNX today.

How to Set Up a New Investment Account on eToro

  1. Click here to get started.
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
  2. Enter your personal details to start your new brokerage account.
  1. Submit your application by clicking the "Create Account" button.
  2. Get started with eToro today
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 3: Deposit funds into your investment account

Now that you have finished signing up on the best stock trading app, you need to deposit funds:

Watch the video below if you need help transferring money into your new investment account.

Get started with eToro today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 4: Evaluate Crinetics Pharmaceuticals stock

Once you have decided on the best place to buy Crinetics Pharmaceuticals stock, it's very important to evaluate their stock before you invest, so you truly comprehend the risk as well as the opportunity.

Crinetics Pharmaceuticals shares quick numbers

CRNX Price
$56.69
1w %
-2.19%
1y %
91.84%
5y %
204.95%
P/E
-15.08x
P/B
5.46x
P/S
3,149.44x
PEG
N/A
Revenue
$1.39M
Earnings
-$258.54M
Fore. Rev. Growth
226.71%
Fore. Earn. Growth
N/A
Market Cap
$4.54B
Next Earnings
Nov 12, 2024
Next Dividend
N/A

Crinetics Pharmaceuticals Fundamentals

WallStreetZen was designed to help average investors do better fundamental analysis in less time.

You can see all of the due diligence checks on CRNX's stock page.

How is CRNX stock valued?

You can use a variety of different financial metrics, analyses, models, and charts to gauge CRNX's true value.

Using relative valuations measures:

  • CRNX could be undervalued based on its P/B ratio of 5.46x, relative to Biotechnology industry P/B ratio of 5.8x

You can do more valuation research on CRNX's stock here.

How do CRNX Financials look?

Positive Financial Indicators:

  • CRNX has a low debt to equity ratio of 0.13.
  • CRNX has cash burn of 185049000. It has sufficient cash and short-term investments to cover this for at least one year.
  • There are more short-term assets than long-term liabilities on the CRNX balance sheet.
  • There are more short-term assets than short-term liabilities on the CRNX balance sheet.
  • CRNX has $864.25M in cash and short term investments. This is sufficient to cover its annual cash burn of $185.05M.

Negative Financial Indicators:

  • CRNX profit margin has gone down from -3,804.1% to -18,667.1% in the past year.
  • Total CRNX debt is higher than 5 years ago, relative to shareholder equity.

Do analysts think it's a good time to buy CRNX stock

Out of 8 Equities analysts who track CRNX, the consensus analyst rating on Crinetics Pharmaceuticals is a Strong Buy

Please keep in mind that analyst ratings are not stock recommendations, nor are they financial advice.

Latest CRNX Analyst Recommendations

Yasmeen Rahimi, a top 3% analyst from Piper Sandler maintains CRNX with a strong buy rating and maintains their CRNX price target from $97.00 to $97.00, on Jul 2, 2024.

Brian Skorney, a top 17% analyst from Baird maintains CRNX with a buy rating and raises their CRNX price target from $52.00 to $62.00, on May 23, 2024.

Jeffrey Hung, a top 12% analyst from Morgan Stanley maintains CRNX with a strong buy rating and raises their CRNX price target from $50.00 to $70.00, on May 23, 2024.

You can dive deeper into what analysts are saying on the Crinetics Pharmaceuticals stock forecast page.

Metrics for Advanced CRNX Traders

SMA10
57.52
SMA20
56.09
SMA50
53.78
SMA100
51.74
SMA200
47.47
MACD
1.04
MACD Signal
1.33
MACD Histogram
-0.29
RSI
55.06
Stochastic %K
48.68
Stochastic %D
54.8
StochRSI %K
8.13
StochRSI %D
12.67

How are CRNX Revenues/Earnings doing?

Last year, CRNX revenue was $1.39M. During the last 5 year, CRNX's revenue has increased by -3.97% per year. This was slower than the Biotechnology industry average of 63.28%.

Find out more about CRNX's earnings and revenue performance here.

Latest Insiders Trades at CRNX

Over the past 12 months, executives and large shareholders at CRNX have sold more shares than they have bought.

Dana Pizzuti, Chief Med and Dev Officer of CRNX, was the latest CRNX insider to sell. They sold $785,306.25 worth of CRNX shares on Oct 3, 2024.

Learn more about who owns CRNX shares here.

Can I get consistent income from CRNX stock?

No, Crinetics Pharmaceuticals doesn't provide an income stream by paying out dividends.

What others are saying about CRNX

One of the reasons eToro is our favorite brokerage is because of its social trading community.

Click below to learn what other traders have to say.

Step 5: Make your CRNX buy order

There are two primary order types:

  • Market order: A market order is an order to buy or sell a security at the best price on the market.
    Market orders are mostly fine for most investors.
  • Limit order: A limit order is an order to buy or sell a stock at a specific price (or better).
    If you want to be sure you're buying or selling at a particular dollar amount limit, place a limit order.

Hit the Open button and your broker will place your order.

If you want additional assistance investing in stocks on eToro, watch the helpful video below:

Open eToro Account

Step 6: Get the latest news on your CRNX position

Now that you own some CRNX stock, you'll want to keep up with your shares.

Start a watchlist to see the latest developments about your CRNX stock.

CRNX Feed

How to Buy Stock in Crinetics Pharmaceuticals

To summarize, here are the 6 steps you need to take to buy Crinetics Pharmaceuticals stock right now:

  1. Figure out where to buy Crinetics Pharmaceuticals stock
  2. Open a brokerage account
  3. Deposit funds into your investment account
  4. Evaluate Crinetics Pharmaceuticals stock
  5. Make your CRNX buy order
  6. Get the latest news on your CRNX position

If you need a brokerage, eToro is our favorite venue.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

If you would like to get updates on your investment in Crinetics Pharmaceuticals, add CRNX to your watchlist below.

NASDAQ: CRNX
$56.69+0.73 (+1.3%)
Updated Nov 1, 2024
Open eToro Account
NASDAQ: CRNX
$56.69+0.73 (+1.3%)
Updated Nov 1, 2024
Open eToro Account

FAQ

How much does it cost to buy one Crinetics Pharmaceuticals share?

As of Nov 1, 2024, it costs $56.69 to buy one share of Crinetics Pharmaceuticals stock.

Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $10, you can buy 0.176 shares of CRNX.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Is now a good time to buy Crinetics Pharmaceuticals stock?

According to 8 Wall Street analysts who monitor Crinetics Pharmaceuticals, their consensus recommendation is to buy Crinetics Pharmaceuticals stock.

What is the best way to buy Crinetics Pharmaceuticals stock?

One way to place an order for Crinetics Pharmaceuticals stock is with a brokerage account.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.